Connor Seabrook is the Administrative Partner of Alliance Technology Ventures. In addition, he has worked with several of ATV’s portfolio companies. As Director of Finance & Administration, he helped AtheroGenics raise $50 million over five years for R&D and oversaw the construction of its facilities. He also has served as CFO for Inhibitex, Helios Health and Somatocor Pharmaceuticals. Prior to joining Alliance at its inception in 1993, Connor was the CFO for Aspen Venture Partners, a $150 million early stage venture capital partnership. Earlier, he was an Associate with 3i Ventures in Boston. Before joining 3i Ventures, he worked at Goldman, Sachs & Co., and served as a lending officer at The United States Trust Company of New York. Connor received his MBA from The Amos Tuck School of Business Administration at Dartmouth College in 1985, and his Bachelor of Science in Environmental Studies and Economics from Trinity College in 1980.
He may be reached on the Internet at seabrook@alliancetechventures.com.
